<!DOCTYPE html>


<style>
    body{
  background: #18181B;
}

.main{
  font-family: "Noto Sans", ui-sans-serif, system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol", "Noto Color Emoji";
  color: #FDFDFD;
}

h1 {
  font-size: 2.5rem;
  color: white;
}

h3 {
  font-size: 1.5rem;
  background: #0c087c;
  padding: 10px;
  margin: 0px;
  border: 1px solid #6b7280;}

.extended-title{
  width:100%;
}

#gsk-overview{
  display:flex;
}

h4 {
  font-size: 1rem;
  background: #27272A;
  padding: 10px;
  margin: 0px;
  border-bottom: 1px solid #6b7280;
}

h2 {
  font-size: 1.5rem;
  margin-top: 3px;
  color:#000000;
}

.header{
  display: flex;
  justify-content: center;
  align-items: center;
}
.header > * {
  margin-inline: 20px;
}

.flex-row {
  display: flex;
  flex-direction: row;
  padding:10px;
  border: 1px solid #27272A;
}

.flex-row>div {
  flex: auto;
  box-sizing: border-box;
  display: flex;
  flex-direction: column;
  justify-content: center;
  align-items: center;
}

progress[value] {
  --background: #6D6D6D;
  -webkit-appearance: none;
  -moz-appearance: none;
  appearance: none;
  border: none;
  height: 4px;
  margin: 0 10px;
  border-radius: 10em;
  background: var(--background);
}

progress[value]::-webkit-progress-bar {
  border-radius: 10em;
  background: var(--background);
}

progress[value]::-webkit-progress-value {
  border-radius: 10em;
  background: var(--color);
}

progress[value]::-moz-progress-bar {
  border-radius: 10em;
  background: var(--color);
}

label {
  font-size: 20px;
  font-weight: bold;
  display: block;
  margin: 20px 0;
}

.tab {
  overflow: hidden;
  border: 1px solid #27272A;
  background-color: #27272A;
}

.tab button {
  background-color: inherit;
  float: left;
  border: none;
  outline: none;
  cursor: pointer;
  padding: 14px 16px;
  transition: 0.3s;
  color: #ffffff;
  font-size:1.2rem;
}

.tab div {
  background-color: inherit;
  float: left;
  border: none;
  outline: none;
  cursor: pointer;
  padding: 14px 16px;
  transition: 0.3s;
  color: #ffffff;
  font-size: 1.2rem;
}

.tab button:hover {
  background-color: #18181B;
}

.tab-title{
  font-size: 1.5rem;
  font-weight: bold;
  margin-bottom:-5px;
}

.tab button.active {
  background-color: #18181B;
  border-top: 1px solid #6b7280;
  border-bottom: 1px solid #18181B;
  border-left: 1px solid #6b7280;
  border-right: 1px solid #6b7280;
}

.tabcontent {
  display: none;
  padding: 6px 12px;
  background: #18181B;
  border: 1px solid #27272A;
  border-top: 1px solid #6b7280;
  margin-top: -2px;
}

#gsk-advice {
  display: flex;
  justify-content: center;
}

#gsk-metrics{
  width:100%;
}

#recommendation {
  margin-top: 20px;
  padding: 20px;
  border-radius: 10px;
  background-color: #e1ce86;
  color: #27272A;
  width:95%;
  box-shadow: 0 4px 8px 0 #000000, 0 6px 20px 0 #000000;
  font-size: 12pt;
}

.separator {
  margin: 20px 0;
}

.separator-border {
  margin: 20px 0;
  border-bottom: 1px solid #6b7280;
}

#gsk-rag{
  margin: 32px 28px;
  padding: 12px 24px;
  background-color: #111516;
}

.section-container {
  margin-bottom: 32px;
}

  .components-container {
    display: flex;
    flex-flow: row wrap;
    align-items: flex-start;
    gap: 0 32px;
  }

    .component-card {
      background-color: #14191B;
      border-radius: 16px;
      padding: 28px 32px 32px 32px;
      display: flex;
      flex-flow: column;
      align-items: center;
      margin-top: 32px;
      flex-grow: 1;
    }

    .component-title {
      font-size: 12px;
      font-weight: 500;
      color: #B1B1B1;
      padding-bottom: 8px;
    }

    .component-value {
      font-size: 32px;
      font-weight: 500;
      padding-bottom: 12px;
    }
      
      .text-green {
        color: #04B543;
      }
      
      .text-orange {
        color: #E76E0F;
      }
      
      .text-red {
        color: #EA3829;
      }

      .tooltip {
        position: relative;
        display: inline-block;
      }

      .tooltip .tooltiptext {
        visibility: hidden;
        width: 120px;
        background-color: #464646;
        color: #E6E6E6;
        text-align: center;
        border-radius: 6px;
        position: absolute;
        z-index: 1;
        top: 150%;
        left: 50%;
        margin-left: -60px;
        font-size: 12px;
        padding: 12px;
      }
      
      .tooltip .tooltiptext::after {
        content: "";
        position: absolute;
        bottom: 100%;
        left: 50%;
        margin-left: -5px;
        border-width: 5px;
        border-style: solid;
        border-color: transparent transparent black transparent;
      }
      
      .tooltip:hover .tooltiptext {
        visibility: visible;
      }

    .overall-card {
      background-color: #026836;
      border-radius: 16px;
      padding: 28px 32px 32px 32px;
      display: flex;
      flex-flow: column;
      align-items: center;
      justify-content: center;
      margin-top: 32px;
      flex-grow: 1;
    }
  
    .overall-title {
      font-size: 12px;
      font-weight: 500;
      color: #E6E6E6;
      padding: 14px 0 8px 0;
      text-transform: uppercase;
     }
  
    .overall-value {
      font-size: 32px;
      font-weight: 500;
      padding-bottom: 12px;
      color: #E6E6E6;
    }

.section-title {
  font-size: 12px;
  color: #B1B1B1;
  margin-bottom: 20px;
  text-align: left;
  width: 100%;
}

.section-content {
  color: #E6E6E6;
  font-size: 20px;
  line-height: 1.5;
}

.section-card {
  background-color: #14191B;
  border-radius: 16px;
  padding: 28px 32px 32px 32px;
  display: flex;
  flex-flow: column;
  align-items: center;
}

.correctness-indicator{
  padding: 20px;
  border-radius: 50px;
  font-size: 16pt;
  box-shadow: 0 4px 8px 0 #000000, 0 6px 20px 0 #000000;
  text-align: center;
}

.metric-title{
  margin: -2px;
  border-bottom: none;
}

.hist-row {
  display: flex;
  flex-direction: row;
  padding: 10px;
  justify-content: space-around;
  width: 85%;
}

.hist-row>div {
  flex: auto;
  box-sizing: border-box;
  display: flex;
  flex-direction: column;
  justify-content: center;
  align-items: center;
  padding-left: 1%;
  padding-right: 1%;
}

.tab-row{
  display: flex;
  flex-direction: column;
  align-items: center;
}

#component-table{
  width:50%;
  margin-top: 10px;
}

.green{
  background-color: #0a980a;
}

.orange {
  background-color: #e5b62a;
}

.red {
  background-color: #ba0e0e;
}

.progress-green {
  --color: #04B543;
}

.progress-orange {
  --color: #E76E0F;
}

.progress-red {
  --color: #EA3829;
}

.corr-plot{
  flex: 1;
  padding-left: 2%;
}

.tooltip-text {
  position: absolute;
  display: none;
  visibility: hidden;
  z-index: 1;
  top: 100%;
  left: 0%;
  width: 100%;
  color: white;
  font-size: 12px;
  background-color: #2d3d4c;
  border-radius: 10px;
  padding: 10px 15px 10px 15px;
}

#fade {
  opacity: 1;
  transition: opacity 0.5s;
}

#delay {
  opacity: 0;
  transition: opacity 0.2s;
  transition-delay: 1s;
}

td {
  position: relative;
}

tr:hover .tooltip-text {
  display: block;
  visibility: visible;
}

.tr:hover #fade {
  opacity: 1;
}

.tr:hover #delay {
  opacity: 1;
}

.callout {
  padding: 0.5rem 1rem 0.5rem 3rem;
  background: #D9EDF9;
  border: 3px solid #0088D1;
  color: #272eb5;
  position: relative;
  max-width: 40rem;
  border-radius: 10px;
  margin-top: 10%;
  font-size: 11pt;
}

.callout-icon {
  content: "";

  /* SVG via a data URI! */
  background-size: cover;
  width: 1.5rem;
  height: 1.5rem;
  display: block;
  position: absolute;
  left: 0.9rem;
  top: 1.1rem;
}

.callout-icon svg{
  fill: #016ca7;
}
.callout p+p {
  margin-top: 1em;
}

.callout a {
  color: #272eb5;
  font-weight: bold;
}

#gsk-logo {
  padding-top: 10px;
}
</style>
<script src="https://cdn.bokeh.org/bokeh/release/bokeh-3.3.4.min.js" integrity="sha384-5QIrjQuyo4I/x6DK/Sau33lcA3hT2TCZGr9vbk+2ebd7Da6FnR1amdM+9B5xOrSf" crossorigin="anonymous"></script>
<script src="https://cdn.bokeh.org/bokeh/release/bokeh-gl-3.3.4.min.js" integrity="sha384-tXTWPp/bAKa+K9RPuXh7DNvye0Mv+P+6y4rAMVy+pWapsnXg9UG7g20WZ0N4i28A" crossorigin="anonymous"></script>





<div class="main">
    <div id="gsk-rag" class="dark:text-white dark:bg-zinc-800 rounded border border-gray-500">
        <div class="header border-b border-b-gray-500">
            
                <svg xmlns="http://www.w3.org/2000/svg" width="60" height="30" viewBox="0 0 30 15" fill="none" id="gsk-logo">
                    <path fill="#fff" fill-rule="evenodd"
                        d="M22.504 1.549a4.196 4.196 0 0 1 2.573-.887v.002a3.783 3.783 0 0 1 2.706 1.086 3.783 3.783 0 0 1 1.126 2.69 3.771 3.771 0 0 1-1.126 2.69 3.77 3.77 0 0 1-2.706 1.085l-4.794.011-2.533 3.467L8.203 15l2.881-3.335a9.829 9.829 0 0 1-4.663-1.68H3.185L0 7.163h3.934C4.263 3.165 8.187 0 12.96 0c2.24 0 4.489.696 6.175 1.909a7.423 7.423 0 0 1 1.882 1.919 4.194 4.194 0 0 1 1.487-2.28ZM7.05 3.249l3.91 3.915h1.505L7.89 2.584a7.773 7.773 0 0 0-.84.665Zm4.079-2.008 5.923 5.923h1.503l-6.086-6.087c-.45.023-.898.078-1.34.164ZM4.574 8.226h-1.77l.784.693h1.584a8.454 8.454 0 0 1-.598-.693Zm9.479 0H5.984c1.469 1.477 3.656 2.377 5.977 2.422l2.092-2.422Zm-2.458 4.472 5.492-1.902 1.878-2.569h-3.508l-3.862 4.47Zm10.361-5.552h3.265a2.714 2.714 0 0 0 1.747-4.648 2.711 2.711 0 0 0-1.888-.773 3.127 3.127 0 0 0-3.123 3.124v2.297Zm3.659-3.73a.677.677 0 1 1-.134 1.348.677.677 0 0 1 .134-1.348Z"
                        clip-rule="evenodd" />
                </svg>
            <h1>RAG Evaluation Toolkit</h1>
        </div>
        
        <div class="section-container">
            <div class="components-container">
                
                <div class="component-card">
                    <div class="component-title">GENERATOR</div>
                    <div class="component-value tooltip  text-orange ">
                        52.0%
                            <span class="tooltiptext" id="fade">The Generator is the LLM inside the RAG to generate the answers.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=52.0 class=" progress-orange ">52.0%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">RETRIEVER</div>
                    <div class="component-value tooltip  text-green ">
                        100.0%
                            <span class="tooltiptext" id="fade">The Retriever fetches relevant documents from the knowledge base according to a user query.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=100.0 class=" progress-green ">100.0%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">REWRITER</div>
                    <div class="component-value tooltip  text-green ">
                        100.0%
                            <span class="tooltiptext" id="fade">The Rewriter modifies the user query to match a predefined format or to include the context from the chat history.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=100.0 class=" progress-green ">100.0%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">ROUTING</div>
                    <div class="component-value tooltip  text-green ">
                        100.0%
                            <span class="tooltiptext" id="fade">The Router filters the query of the user based on his intentions (intentions detection).</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=100.0 class=" progress-green ">100.0%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">KNOWLEDGE_BASE</div>
                    <div class="component-value tooltip  text-orange ">
                        61.9%
                            <span class="tooltiptext" id="fade">The knowledge base is the set of documents given to the RAG to generate the answers. Its scores is computed differently from the other components: it is the difference between the maximum and minimum correctness score across all the topics of the knowledge base.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=61.904761904761905 class=" progress-orange ">61.9%</progress>
                    </div>
                </div>
                
                <div class="overall-card">
                    <div class="overall-title">Overall Correctness Score</div>
                    <div class="overall-value">52%</div>
                </div>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">
                <div class="section-title">RECOMMENDATION</div>
                <span class="section-content">Focus on improving the retrieval and generation components for complex questions, as they have the lowest overall score among all question types.</span>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">
                <div class="section-title">CORRECTNESS BY TOPIC</div>
                    <script type="text/javascript">
        (function() {
  const fn = function() {
    Bokeh.safely(function() {
      (function(root) {
        function embed_document(root) {
        const docs_json = '{"cf04509d-7aa6-4cbc-81ef-15d7bb2cd413":{"version":"3.4.3","title":"Bokeh Application","roots":[{"type":"object","name":"Figure","id":"p2571","attributes":{"height":350,"width_policy":"max","x_range":{"type":"object","name":"DataRange1d","id":"p2573","attributes":{"start":0}},"y_range":{"type":"object","name":"FactorRange","id":"p2580","attributes":{"factors":["Lice Treatment","Others","Pregnancy and Medication"]}},"x_scale":{"type":"object","name":"LinearScale","id":"p2581"},"y_scale":{"type":"object","name":"CategoricalScale","id":"p2582"},"title":{"type":"object","name":"Title","id":"p2578","attributes":{"text_color":"#E0E0E0","text_font":"Helvetica","text_font_size":"14pt"}},"outline_line_color":"#E0E0E0","outline_line_alpha":0.25,"renderers":[{"type":"object","name":"GlyphRenderer","id":"p2600","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p2568","attributes":{"selected":{"type":"object","name":"Selection","id":"p2569","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p2570"},"data":{"type":"map","entries":[["correctness",{"type":"ndarray","array":{"type":"bytes","data":"t23btm3bUUCqqqqqqqpAQFVVVVVVVUdA"},"shape":[3],"dtype":"float64","order":"little"}],["metadata_values",["Lice Treatment","Others","Pregnancy and Medication"]],["colors",["#006837","#a50026","#fdc675"]]]}}},"view":{"type":"object","name":"CDSView","id":"p2601","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p2602"}}},"glyph":{"type":"object","name":"HBar","id":"p2597","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"#1f77b4"},"fill_color":{"type":"value","value":"#14191B"}}},"nonselection_glyph":{"type":"object","name":"HBar","id":"p2598","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"#1f77b4"},"line_alpha":{"type":"value","value":0.1},"fill_color":{"type":"value","value":"#14191B"},"fill_alpha":{"type":"value","value":0.1},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"HBar","id":"p2599","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"#1f77b4"},"line_alpha":{"type":"value","value":0.2},"fill_color":{"type":"value","value":"#14191B"},"fill_alpha":{"type":"value","value":0.2},"hatch_alpha":{"type":"value","value":0.2}}}}},{"type":"object","name":"GlyphRenderer","id":"p2609","attributes":{"data_source":{"id":"p2568"},"view":{"type":"object","name":"CDSView","id":"p2610","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p2611"}}},"glyph":{"type":"object","name":"HBar","id":"p2606","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"white"},"line_width":{"type":"value","value":2},"fill_color":{"type":"value","value":"#78BBFA"},"fill_alpha":{"type":"value","value":0.7}}},"nonselection_glyph":{"type":"object","name":"HBar","id":"p2607","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"white"},"line_alpha":{"type":"value","value":0.1},"line_width":{"type":"value","value":2},"fill_color":{"type":"value","value":"#78BBFA"},"fill_alpha":{"type":"value","value":0.1},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"HBar","id":"p2608","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"white"},"line_alpha":{"type":"value","value":0.2},"line_width":{"type":"value","value":2},"fill_color":{"type":"value","value":"#78BBFA"},"fill_alpha":{"type":"value","value":0.2},"hatch_alpha":{"type":"value","value":0.2}}}}},{"type":"object","name":"GlyphRenderer","id":"p2619","attributes":{"visible":false,"data_source":{"type":"object","name":"ColumnDataSource","id":"p2613","attributes":{"selected":{"type":"object","name":"Selection","id":"p2614","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p2615"},"data":{"type":"map","entries":[["x",[0]],["y",[0]]]}}},"view":{"type":"object","name":"CDSView","id":"p2620","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p2621"}}},"glyph":{"type":"object","name":"Line","id":"p2616","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"line_color":"#EA3829","line_width":2,"line_dash":[6]}},"nonselection_glyph":{"type":"object","name":"Line","id":"p2617","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"line_color":"#EA3829","line_alpha":0.1,"line_width":2,"line_dash":[6]}},"muted_glyph":{"type":"object","name":"Line","id":"p2618","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"line_color":"#EA3829","line_alpha":0.2,"line_width":2,"line_dash":[6]}}}}],"toolbar":{"type":"object","name":"Toolbar","id":"p2579","attributes":{"tools":[{"type":"object","name":"HoverTool","id":"p2593","attributes":{"renderers":"auto","tooltips":[["topic","@metadata_values"],["Correctness","@correctness{0.00}"]]}}]}},"toolbar_location":null,"left":[{"type":"object","name":"CategoricalAxis","id":"p2588","attributes":{"ticker":{"type":"object","name":"CategoricalTicker","id":"p2589"},"formatter":{"type":"object","name":"CategoricalTickFormatter","id":"p2590"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p2591"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"below":[{"type":"object","name":"LinearAxis","id":"p2583","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p2584","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p2585"},"axis_label":"Correctness (%)","axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p2586"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"center":[{"type":"object","name":"Grid","id":"p2587","attributes":{"axis":{"id":"p2583"},"grid_line_color":"#E0E0E0","grid_line_alpha":0.25}},{"type":"object","name":"Grid","id":"p2592","attributes":{"dimension":1,"axis":{"id":"p2588"},"grid_line_color":"#E0E0E0","grid_line_alpha":0.25}},{"type":"object","name":"Span","id":"p2612","attributes":{"location":52.0,"dimension":"height","line_color":"#EA3829","line_width":2,"line_dash":[6]}},{"type":"object","name":"Legend","id":"p2622","attributes":{"border_line_alpha":0,"background_fill_color":"#111516","background_fill_alpha":0.5,"label_text_color":"#E0E0E0","label_text_font":"Helvetica","label_text_font_size":"1.025em","label_standoff":8,"glyph_width":15,"spacing":8,"items":[{"type":"object","name":"LegendItem","id":"p2623","attributes":{"label":{"type":"value","value":"Correctness on the entire Testset"},"renderers":[{"id":"p2619"}]}}]}}],"background_fill_color":"#14191B","border_fill_color":"#15191C"}}]}}';
        const render_items = [{"docid":"cf04509d-7aa6-4cbc-81ef-15d7bb2cd413","roots":{"p2571":"abfc944e-7603-4d7d-8c45-8f7a94f5e0bd"},"root_ids":["p2571"]}];
        root.Bokeh.embed.embed_items(docs_json, render_items);
        }
        if (root.Bokeh !== undefined) {
          embed_document(root);
        } else {
          let attempts = 0;
          const timer = setInterval(function(root) {
            if (root.Bokeh !== undefined) {
              clearInterval(timer);
              embed_document(root);
            } else {
              attempts++;
              if (attempts > 100) {
                clearInterval(timer);
                console.log("Bokeh: ERROR: Unable to run BokehJS code because BokehJS library is missing");
              }
            }
          }, 10, root)
        }
      })(window);
    });
  };
  if (document.readyState != "loading") fn();
  else document.addEventListener("DOMContentLoaded", fn);
})();
    </script>

                <div id="abfc944e-7603-4d7d-8c45-8f7a94f5e0bd" data-root-id="p2571" style="display: contents;"></div>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">
                <div class="section-title">KNOWLEDGE BASE OVERVIEW</div>
                    <script type="text/javascript">
        (function() {
  const fn = function() {
    Bokeh.safely(function() {
      (function(root) {
        function embed_document(root) {
        const docs_json = '{"f8910ba5-41ae-4b2a-8117-cddff78f25c8":{"version":"3.4.3","title":"Bokeh Application","roots":[{"type":"object","name":"Tabs","id":"p2504","attributes":{"sizing_mode":"stretch_width","tabs":[{"type":"object","name":"TabPanel","id":"p2441","attributes":{"title":"Topic exploration","child":{"type":"object","name":"Figure","id":"p2396","attributes":{"sizing_mode":"stretch_width","x_range":{"type":"object","name":"Range1d","id":"p2405","attributes":{"start":6.442548179626465,"end":15.825972747802734}},"y_range":{"type":"object","name":"Range1d","id":"p2406","attributes":{"start":-7.868514358997345,"end":-2.0408262610435486}},"x_scale":{"type":"object","name":"LinearScale","id":"p2407"},"y_scale":{"type":"object","name":"LinearScale","id":"p2408"},"title":{"type":"object","name":"Title","id":"p2403","attributes":{"text_color":"#E0E0E0","text_font":"Helvetica","text_font_size":"14pt"}},"outline_line_color":"#E0E0E0","outline_line_alpha":0.25,"renderers":[{"type":"object","name":"GlyphRenderer","id":"p2436","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p2393","attributes":{"selected":{"type":"object","name":"Selection","id":"p2394","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p2395"},"data":{"type":"map","entries":[["x",{"type":"ndarray","array":{"type":"bytes","data":"QDUKQcDUDUF1RQFBgF4AQd9P9ECEsfFAHvEKQTdzEkE3BRFBDNraQLhC10AuV+pAV74EQWQEFkHehOlAW38HQUav/0AZuBhBb/wgQZb0LUGYrytBrJ8iQe19NUHPt0JB4WYqQVyoN0FxljpBTegzQUSvJ0G1oStBsd47QQCfRkE="},"shape":[32],"dtype":"float32","order":"little"}],["y",{"type":"ndarray","array":{"type":"bytes","data":"9PKZwBIxscDbIrvAmYlcwK9wfsBy5pPAX8ZAwHf8ZMANVozA7OiawFuGdcB6+lTAhmaEwAuUoMCCyrfALfrKwFKmo8BvPLvA2TChwD7jocAittzA6nPUwKcg1MBYKsDAgi6+wNuDw8Dk8KnA1VJewAFAacCP9YjAO0KPwD3PpMA="},"shape":[32],"dtype":"float32","order":"little"}],["topic",["Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others","Others"]],["id",[0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,26,27,28,29,30,31,32,33]],["content",["CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE -\\nchlordiazepoxide hydrochloride and clidinium bromide capsule \\n \\nAlembic Pharmaceuticals Inc.\\n----------\\nChlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP\\nfor oral use\\nWARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE,\\nMISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL\\nREACTIONS\\n \\nConcomitant use of benzodiazepines and opioids may result in\\nprofound sedation, respiratory depression, coma, and death. Reserve\\nconcomitan...","Each chlordiazepoxide hydrochloride and clidinium bromide capsule, USP contains the\\nactive ingredients 5 mg chlordiazepoxide hydrochloride, USP and 2.5 mg clidinium\\nbromide, USP. Each capsule also contains the inactive ingredients lactose monohydrate,\\ncorn starch, talc, titanium dioxide, FD&amp;C Green 3, D&amp;C Yellow 10 and gelatin. The empty\\nhard gelatin capsule shells are printed with edible black ink containing shellac, propylene\\nglycol,  black iron oxide and potassium hydroxide.\\nChlordiazepoxide ...","the maximum recommended human dose of 40 mg/day, based on body surface area)\\nexhibited major skeletal defects.\\nTwo series of reproduction experiments with clidinium bromide were carried out in rats,\\nemploying dosages of 2.5 and 10 mg/kg daily (1.2 and 4.9 times, respectively, the\\nmaximum recommended clinical dose of 20 mg/day, based on body surface area) in\\neach experiment. In the first experiment, clidinium bromide was administered for a 9-\\nweek interval prior to mating; no untoward effect on f...","Risks From Concomitant Use with Opioids\\nConcomitant use of benzodiazepines, including chlordiazepoxide hydrochloride and\\nclidinium bromide and opioids may result in profound sedation, respiratory depression,\\ncoma, and death. Because of these risks, reserve concomitant prescribing of these\\ndrugs -in patients for whom alternative treatment options are inadequate.\\nObservational studies have demonstrated that concomitant use of opioid analgesics and\\nbenzodiazepines increases the risk of drug-related...","those who have had longer durations of use.\\nAcute Withdrawal Reactions\\nThe continued use of benzodiazepines, including chlordiazepoxide hydrochloride and\\nclidinium bromide capsules, may lead to clinically significant physical dependence. Abrupt\\ndiscontinuation or rapid dosage reduction of chlordiazepoxide hydrochloride and\\nclidinium bromide capsules after continued use, or administration of flumazenil (a\\nbenzodiazepine antagonist) may precipitate acute withdrawal reactions, which can be\\nlife-thr...","as the MAO inhibitors and phenothiazines are to be used. The usual precautions in\\ntreating patients with impaired renal or hepatic function should be observed.\\nParadoxical reactions to chlordiazepoxide hydrochloride, e.g., excitement, stimulation\\nand acute rage, have been reported in psychiatric patients and should be watched for\\nduring chlordiazepoxide hydrochloride and clidinium bromide capsules therapy. The\\nusual precautions are indicated when chlordiazepoxide hydrochloride is used in the\\ntre...","Pregnancy\\n). Instruct patients to inform their healthcare provider if they are pregnant.\\nNursing\\nInstruct patients to notify their healthcare provider if they are breastfeeding or intend to\\nbreastfeed (see \\nPRECAUTIONS, Nursing Mothers\\n).\\nDrug Interactions\\nOpioids\\n \\nThe concomitant use of benzodiazepines, including chlordiazepoxide hydrochloride, a\\ncomponent of chlordiazepoxide hydrochloride and clidinium bromide capsules and\\nopioids increases the risk of respiratory depression because of action...","defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to\\n20%, respectively.\\nClinical Considerations\\nFetal/Neonatal Adverse Reactions\\nBenzodiazepines cross the placenta and may produce respiratory depression, hypotonia\\nand sedation in neonates. Monitor neonates exposed to chlordiazepoxide hydrochloride\\nand clidinium bromide capsules, which contains a benzodiazepine (chlordiazepoxide\\nhydrochloride), during pregnancy or labor for signs of sedation, respiratory depression,...","Reproduction studies in rats fed chlordiazepoxide hydrochloride, 10, 20 and 80 mg/kg\\ndaily (2.4, 4.8 and 19.4 times respectively, the maximum recommended clinical dose of\\n40 mg/day, based on body surface area), and bred through one or two matings showed\\nno adverse effects on lactation of the dams.\\nClidinium Bromide\\nThere are no data on the presence of clidinium in either human or animal milk, the\\neffects on the breastfed infant, or the effects on milk production. As with other\\nanticholinergic dr...","instances syncope has been reported.\\nOther adverse reactions reported during therapy with chlordiazepoxide hydrochloride\\ninclude isolated instances of skin eruptions, edema, minor menstrual irregularities,\\nnausea and constipation, extrapyramidal symptoms, as well as increased and decreased\\nlibido. Such side effects have been infrequent and are generally controlled with reduction\\nof dosage. Changes in EEG patterns (low-voltage fast activity) have been observed in\\npatients during and after chlordi...","Abuse and misuse of benzodiazepines often (but not always) involve the use of doses\\ngreater than the maximum recommended dosage and commonly involve concomitant\\nuse of other medications, alcohol, and/or illicit substances, which is associated with an\\nincreased frequency of serious adverse outcomes, including respiratory depression,\\noverdose, or death. Benzodiazepines are often sought by individuals who abuse drugs\\nand other substances, and by individuals with addictive disorders (see \\nWARNINGS\\n)...","seizures and suicidality.\\nProtracted Withdrawal Syndrome\\nProtracted withdrawal syndrome associated with benzodiazepines is characterized by\\nanxiety, cognitive impairment, depression, insomnia, formication, motor symptoms (e.g.,\\nweakness, tremor, muscle twitches), paresthesia, and tinnitus that persists beyond 4 to\\n6 weeks after initial benzodiazepine withdrawal. Protracted withdrawal symptoms may\\nlast weeks to more than 12 months. As a result, there may be difficulty in differentiating\\nwithdrawa...","overdosage. Anticholinergic drugs usually increase heart rate and blood pressure. In\\nmanaging benzodiazepine overdosage, employ general supportive measures, including\\nintravenous fluids, and airway management.\\nFlumazenil, a specific benzodiazepine receptor antagonist is indicated for the complete\\nor partial reversal of the sedative effects of benzodiazepines in the management of\\nbenzodiazepine overdosage. Use of flumazenil may increase the risk of seizures in\\nmixed overdosage with drugs that may...","on cap and \\u201c333\\u201d on body with black ink, filled with white to off white powder.\\nBottle of 100 capsules with child resistant closure, NDC 62332-744-31\\nBottle of 1000 capsules, NDC 62332-744-91\\nStore at 25\\u00b0C (77\\u00b0F); excursions permitted to 15\\u00b0 to 30\\u00b0C (59\\u00b0 to 86\\u00b0F) [see USP\\nControlled Room Temperature]. Protect from light.\\nKeep out of reach of children.\\nDispense in tight, light-resistant container as defined in USP/NF.\\nMedication Guide available at \\nhttps://www.alembicusa.com/medicationguide.aspx ...","bromide capsules, which can lead to overdose or death. \\n        o \\nSerious side effects including coma and death have happened in people\\nwho have abused or misused benzodiazepines, including chlordiazepoxide\\nhydrochloride and clidinium bromide capsules. \\nThese serious side effects may also\\ninclude delirium, paranoia, suicidal thoughts or actions, seizures, and difficulty breathing.\\nCall your healthcare provider or go to the nearest hospital emergency room\\nright away if you get any of these serio...","clidinium bromide capsules may harm others. Tell your healthcare provider if you have\\nabused or been dependent on alcohol, prescription medicines or street drugs. \\n\\u2022 It is not known if chlordiazepoxide hydrochloride and clidinium bromide capsule is safe\\nand effective in children. \\n \\nDo not take chlordiazepoxide hydrochloride and clidinium bromide capsules if\\nyou: \\n\\u2022 have glaucoma \\n\\u2022 have an enlarged prostate \\n\\u2022 have a blockage of your bladder that causes problems with urination \\n\\u2022 are allergic t...","hydrochloride and clidinium bromide capsules or suddenly stop taking chlordiazepoxide\\nhydrochloride and clidinium bromide capsules without talking with your healthcare\\nprovider. \\n\\u2022 If you take too much chlordiazepoxide hydrochloride and clidinium bromide capsules,\\ncall your healthcare provider or go to the nearest hospital emergency room right away. \\nWhat are the possible side effects of chlordiazepoxide hydrochloride and\\nclidinium bromide capsules? \\nChlordiazepoxide hydrochloride and clidinium ...","that is written for health professionals.\\nWhat are the ingredients in chlordiazepoxide hydrochloride and clidinium\\nbromide capsules? \\nActive ingredients:\\n chlordiazepoxide hydrochloride and clidinium bromide \\nInactive ingredients: \\nlactose monohydrate, corn starch, talc, titanium dioxide, FD&amp;C\\nGreen 3, D&amp;C Yellow 10 and gelatin. The empty hard gelatin capsule shells are printed\\nwith edible black ink containing shellac, propylene glycol,  iron oxide and black iron oxide\\nand potassium hydroxide. \\n...","CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE  \\nchlordiazepoxide hydrochloride and clidinium bromide capsule\\nProduct Information\\nProduct Type\\nHUMAN PRESCRIPTION DRUG\\nItem Code (Source)\\nNDC:62332-744\\nRoute of Administration\\nORAL\\nDEA Schedule\\nCIV    \\nActive Ingredient/Active Moiety\\nIngredient Name\\nBasis of Strength\\nStrength\\nCHLORDIAZEPOXIDE HYDROCHLORIDE\\n (UNII: MFM6K1XWDK)\\n(CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR)\\nCHLORDIAZEPOXIDE\\nHYDROCHLORIDE\\n5 mg\\nCLIDINIUM BROMIDE\\n (UNII: 91ZQW5JF1Z) \\n(CLIDI...","Alembic Pharmaceuticals Inc.\\nPOTASSIUM HYDROXIDE\\n (UNII: WZH3C48M4T)\\n \\nPROPYLENE GLYCOL\\n (UNII: 6DC9Q167V3)\\n \\nProduct Characteristics\\nColor\\nGREEN (Light green opaque cap) , GREEN (Light green opaque body)\\nScore\\nno score\\nShape\\nCAPSULE\\nSize\\n16mm\\nFlavor\\nImprint Code\\nA;333\\nContains\\n    \\nPackaging\\n#\\nItem Code\\nPackage Description\\nMarketing Start\\nDate\\nMarketing End\\nDate\\n1\\nNDC:62332-744-\\n31\\n100 \\nin 1 BOTTLE; Type 0: Not a Combination\\nProduct\\n10/04/2023\\n2\\nNDC:62332-744-\\n91\\n1000 \\nin 1 BOTTLE; Type 0: Not ...","IVERMECTIN- ivermectin lotion \\n \\nWalgreen Company\\n----------\\nIvermectin\\nDrug Facts\\nActive ingredient\\nIvermectin 0.5%\\nPurpose\\nLice treatment\\nUse\\ntreats head lice\\nWarnings\\nFor external use only. Use only on the scalp.\\nDo not use\\non children under 6 months of age\\nnear the eyes\\ninside the nose, ear, mouth, or vagina\\non lice in eyebrows or eyelashes. See a doctor if lice are present in these areas.\\nAsk a doctor before use if you\\nhave any skin conditions or sensitivities\\nare pregnant or plan to become...","If pregnant or breastfeeding,\\n ask a health professional before use.\\nKeep out of reach of children.\\nIf swallowed, get medical help or contact a Poison Control Center (1-800-222-1222)\\nright away.\\nDirections\\nImportant: Read warnings before use\\nchildren 6 months of age to under 12 years of age: an adult should\\nsupervise use\\nadults and children 6 months of age and over:\\nInspect\\nall household members should be checked by another person for lice and/or nits\\n(eggs)\\nuse a magnifying glass in bright ligh...","this is a single use product. Discard tube after use.\\ndo not use again on the same person and same lice infestation without talking to a\\nhealthcare provider first\\nif infestation continues, see a doctor for other treatments\\nmachine wash any bedding and clothing used by anyone having lice. Machine wash at\\nhigh temperatures (150\\u00b0F) and tumble in a hot dryer for 20 minutes.\\nafter finishing treatment with lice medicine, check everyone in your family for lice\\nafter one week. Consider treatment for tho...","1\\nTUBE\\nNET WT 4 OZ (117 g)","IVERMECTIN","ivermectin lotion\\nProduct Information\\nProduct Type\\nHUMAN OTC DRUG\\nItem Code (Source)\\nNDC:0363-4230\\nRoute of Administration\\nTOPICAL\\nActive Ingredient/Active Moiety\\nIngredient Name\\nBasis of Strength\\nStrength\\nIvermectin\\n (UNII: 8883YP2R6D) \\n(Ivermectin - UNII:8883YP2R6D)\\nIvermectin\\n5 mg  in 1 g\\nInactive Ingredients\\nIngredient Name\\nStrength\\nbutylated hydroxyanisole\\n (UNII: REK4960K2U)\\n \\ncastor oil\\n (UNII: D5340Y2I9G)\\n \\ncetyl alcohol\\n (UNII: 936JST6JCN)\\n \\nANHYDROUS CITRIC ACID\\n (UNII: XF417D3PSL)\\n \\nc...","Walgreen Company\\nMarketing Information\\nMarketing\\nCategory\\nApplication Number or Monograph\\nCitation\\nMarketing Start\\nDate\\nMarketing End\\nDate\\nANDA\\nANDA210720\\n05/06/2020\\nLabeler - \\nWalgreen Company \\n(008965063)\\n \\nRevised: 1/2022","NYQUIL SEVERE COLD AND FLU- acetaminophen, dextromethorphan hydrobromide,\\ndoxylamine succinate, phenylephrine hydrochloride tablet, coated \\n \\nSavings Distributors LLC\\nDisclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they\\ncomply with applicable regulations and policies. FDA has not evaluated whether this product complies.\\n----------\\nNyQuil Severe Cold &amp; Flu\\nDrug Facts\\nActive ingredients (in each caplet)\\nAcetaminophen 325 mg\\nDextromethorphan HBr 10 m...","Sore throat warning:\\n If sore throat is severe, persists for more than 2 days, is accompanied or\\nfollowed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.\\nDo not use\\n\\u2022 with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure\\nwhether a drug contains acetaminophen, ask a doctor or pharmacist.\\n\\u2022 if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for\\ndepression, psychiatric or emotional conditions...","children under 4 yrs \\ndo not use\\nOther Information\\n\\u2022 do not exceed 25\\u00baC\\nInactive ingredients\\ncrospovidone, D&amp;C Yellow No.10 Aluminum Lake, \\nFD&amp;C Blue No.1 Aluminum Lake, FD&amp;C Blue\\nNo.2 Aluminum Lake,FD&amp;C Yellow No.6 Aluminum Lake, flavor, magnesium stearate, microcrystalline\\ncellulose, polyethylene glycol, polyvinyl alcohol, povidone, pregelatinized starch, silicon dioxide,\\nstearic acid, talc, titanium dioxide\\nQuestions?\\n1-800-362-1683\\nPackage Label\\nNYQUIL SEVERE COLD AND FLU","acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride tablet, coated\\nProduct Information\\nProduct Type\\nHUMAN OTC DRUG\\nItem Code (Source)\\nNDC:73097-009(NDC:37000-813)\\nRoute of Administration\\nORAL\\nActive Ingredient/Active Moiety\\nIngredient Name\\nBasis of Strength\\nStrength\\nACETAMINOPHEN\\n (UNII: 362O9ITL9D) \\n(ACETAMINOPHEN - UNII:362O9ITL9D)\\nACETAMINOPHEN\\n325 mg\\nDEXTROMETHORPHAN HYDROBROMIDE\\n (UNII: 9D2RTI9KYH)\\n(DEXTROMETHORPHAN - UNII:7355X3ROTS)\\nDEXTROMETHOR...","Savings Distributors LLC\\n3\\nNDC:73097-009-20\\n40 \\nin 1 CARTON\\n07/08/2019\\n3\\n2 \\nin 1 POUCH; Type 0: Not a Combination Product\\nMarketing Information\\nMarketing Category\\nApplication Number or Monograph Citation\\nMarketing Start Date\\nMarketing End Date\\nOTC monograph final\\npart341\\n07/08/2019\\nLabeler - \\nSavings Distributors LLC \\n(010527359)\\n \\nRevised: 7/2019"]],["color",{"type":"ndarray","array":["#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999","#999"],"shape":[32],"dtype":"object","order":"little"}]]}}},"view":{"type":"object","name":"CDSView","id":"p2437","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p2438"}}},"glyph":{"type":"object","name":"Scatter","id":"p2433","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.7},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.7}}},"nonselection_glyph":{"type":"object","name":"Scatter","id":"p2434","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.1},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.1},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"Scatter","id":"p2435","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.2},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.2}}}}}],"toolbar":{"type":"object","name":"Toolbar","id":"p2404","attributes":{"logo":"grey","tools":[{"type":"object","name":"HoverTool","id":"p2419","attributes":{"renderers":"auto","tooltips":"\\n    &lt;div style=\\"width:400px;\\"&gt;\\n    &lt;b&gt;Document id:&lt;/b&gt; @id &lt;br&gt;\\n    &lt;b&gt;Topic:&lt;/b&gt; @topic &lt;br&gt;\\n    &lt;b&gt;Document Content:&lt;/b&gt; @content\\n    &lt;/div&gt;\\n    "}},{"type":"object","name":"PanTool","id":"p2420"},{"type":"object","name":"WheelZoomTool","id":"p2421","attributes":{"renderers":"auto"}},{"type":"object","name":"BoxZoomTool","id":"p2422","attributes":{"overlay":{"type":"object","name":"BoxAnnotation","id":"p2423","attributes":{"syncable":false,"level":"overlay","visible":false,"left":{"type":"number","value":"nan"},"right":{"type":"number","value":"nan"},"top":{"type":"number","value":"nan"},"bottom":{"type":"number","value":"nan"},"left_units":"canvas","right_units":"canvas","top_units":"canvas","bottom_units":"canvas","line_color":"black","line_alpha":1.0,"line_width":2,"line_dash":[4,4],"fill_color":"lightgrey","fill_alpha":0.5}}}},{"type":"object","name":"ResetTool","id":"p2428"},{"type":"object","name":"SaveTool","id":"p2429"}]}},"left":[{"type":"object","name":"LinearAxis","id":"p2414","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p2415","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p2416"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p2417"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"below":[{"type":"object","name":"LinearAxis","id":"p2409","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p2410","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p2411"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p2412"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"center":[{"type":"object","name":"Grid","id":"p2413","attributes":{"axis":{"id":"p2409"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Grid","id":"p2418","attributes":{"dimension":1,"axis":{"id":"p2414"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Legend","id":"p2439","attributes":{"title":"Knowledge Base Tospics","title_text_color":"#B1B1B1","title_text_font_style":"bold","border_line_alpha":0,"background_fill_color":"#111516","background_fill_alpha":0.5,"label_text_color":"#E0E0E0","label_text_font":"Helvetica","label_text_font_size":"1.025em","label_standoff":8,"glyph_width":15,"spacing":8,"items":[{"type":"object","name":"LegendItem","id":"p2440","attributes":{"label":{"type":"value","value":"Others"},"renderers":[{"id":"p2436"}],"index":0}}]}}],"background_fill_color":"#14191B","border_fill_color":"#15191C"}}}},{"type":"object","name":"TabPanel","id":"p2503","attributes":{"title":"Failures","child":{"type":"object","name":"Figure","id":"p2446","attributes":{"sizing_mode":"stretch_width","x_range":{"type":"object","name":"Range1d","id":"p2455","attributes":{"start":6.442548179626465,"end":15.825972747802734}},"y_range":{"type":"object","name":"Range1d","id":"p2456","attributes":{"start":-7.868514358997345,"end":-2.0408262610435486}},"x_scale":{"type":"object","name":"LinearScale","id":"p2457"},"y_scale":{"type":"object","name":"LinearScale","id":"p2458"},"title":{"type":"object","name":"Title","id":"p2453","attributes":{"text_color":"#E0E0E0","text_font":"Helvetica","text_font_size":"14pt"}},"outline_line_color":"#E0E0E0","outline_line_alpha":0.25,"renderers":[{"type":"object","name":"GlyphRenderer","id":"p2485","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p2442","attributes":{"selected":{"type":"object","name":"Selection","id":"p2443","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p2444"},"data":{"type":"map","entries":[["x",{"type":"ndarray","array":{"type":"bytes","data":"dUUBQZb0LUHhZipB30/0QM+3QkE3cxJBQDUKQRm4GEGx3jtBZAQWQVe+BEGYrytBwNQNQd6E6UC4QtdATegzQXGWOkFbfwdBLlfqQISx8UBGr/9ADNraQB7xCkEAn0ZBb/wgQQ=="},"shape":[25],"dtype":"float32","order":"little"}],["y",{"type":"ndarray","array":{"type":"bytes","data":"2yK7wD7jocCCLr7Ar3B+wFgqwMB3/GTA9PKZwG88u8A7Qo/AC5SgwIZmhMAittzAEjGxwILKt8BbhnXA1VJewOTwqcAt+srAevpUwHLmk8BSpqPA7OiawF/GQMA9z6TA2TChwA=="},"shape":[25],"dtype":"float32","order":"little"}],["topic",["Pregnancy and Medication","Lice Treatment","Others","Pregnancy and Medication","Lice Treatment","Pregnancy and Medication","Pregnancy and Medication","Others","Lice Treatment","Pregnancy and Medication","Pregnancy and Medication","Lice Treatment","Pregnancy and Medication","Pregnancy and Medication","Pregnancy and Medication","Lice Treatment","Lice Treatment","Pregnancy and Medication","Pregnancy and Medication","Pregnancy and Medication","Pregnancy and Medication","Others","Pregnancy and Medication","Lice Treatment","Pregnancy and Medication"]],["correctness",[false,false,false,false,false,false,true,true,true,false,true,true,true,false,true,true,true,true,false,false,false,false,true,true,true]],["questions",["What medical conditions or situations would make it unsafe to use chlordiazepoxide hydrochloride and clidinium bromide capsules?","What is the specific color of the capsule for the product with NDC code 62332-744-31 according to the provided document?","What specific drug is referenced in the provided context?","What are the potential withdrawal symptoms that can occur as a result of abrupt discontinuation or rapid dosage reduction of benzodiazepines, and how long can these withdrawal symptoms persist in some cases?","What is the weight of the tube in grams according to document 23?","What are the potential fetal/neonatal adverse reactions that may arise as a result of benzodiazepines crossing the placenta, particularly in neonates exposed to chlordiazepoxide hydrochloride and clidinium bromide capsules during pregnancy or labor?","What severe consequences may arise from the simultaneous use of benzodiazepines and opioids, and what precautions should be taken to mitigate these risks?","What are the active ingredients present in chlordiazepoxide hydrochloride and clidinium bromide capsules according to the provided health professional document?","What are the names and strengths of the active ingredients found in the tablet identified by the item code NDC:73097-009?","What are the potential dangers associated with the consumption of chlordiazepoxide hydrochloride and clidinium bromide capsules when combined with opioid medications, alcohol, or other central nervous system depressants?","What factors should be taken into consideration when determining the maintenance dose for chlordiazepoxide hydrochloride and clidinium bromide capsules, and what is the usual recommended maintenance dose regimen for this medication?","What specific skin condition is Ivermectin lotion primarily used to treat, and what are the restrictions for its application?","What are the active ingredients present in each chlordiazepoxide hydrochloride and clidinium bromide capsule, USP, and can you list them individually?","What are the medical conditions for which chlordiazepoxide hydrochloride and clidinium bromide capsule is prescribed, and what precautions should be taken to prevent misuse and abuse of this medication?","What are some of the severe adverse reactions that have been reported specifically with benzodiazepine abuse and/or misuse, and what factors are often associated with an increased risk of these reactions?","What are the specific active ingredients present in NyQuil Severe Cold &amp; Flu caplets and what are their respective purposes according to the drug facts provided?","What is the specific date when Walgreen Company began its marketing activities according to the provided document?","What are the specific medical conditions and circumstances that would prevent someone from taking chlordiazepoxide hydrochloride and clidinium bromide capsules?","What are the potential signs and symptoms associated with an anticholinergic overdosage, both in terms of peripheral and central effects, and how do benzodiazepines play a role in the treatment of such toxicity?","What are the important considerations that patients should be made aware of regarding the use of chlordiazepoxide hydrochloride and clidinium bromide capsules, particularly in terms of potential abuse, withdrawal reactions, and concomitant use with other medications?","What are the potential side effects that individuals may experience when taking chlordiazepoxide hydrochloride and clidinium bromide capsules, besides the common ones mentioned in the document?","What are some of the adverse reactions that have been reported during therapy with chlordiazepoxide hydrochloride and clidinium bromide capsules, including specific symptoms like dryness of the mouth, blurring of vision, urinary hesitancy, and constipation?","What actions should patients take if they are pregnant or breastfeeding while using chlordiazepoxide hydrochloride and clidinium bromide capsules, considering the potential risks and effects on neonates?","When did the marketing of the product from Savings Distributors LLC begin according to the provided document?","What are the names and strengths of the active ingredients present in the chlordiazepoxide hydrochloride and clidinium bromide capsule?"]],["agent_answer",["According to the provided context, chlordiazepoxide hydrochloride and clidinium bromide capsules are contraindicated in the presence of:\\n\\n1. Glaucoma\\n2. Prostatic hypertrophy\\n3. Benign bladder neck obstruction\\n\\nThese medical conditions or situations would make it unsafe to use chlordiazepoxide hydrochloride and clidinium bromide capsules.","I don&#x27;t know. The provided document does not mention a product with an NDC code of 62332-744-31.","The specific drug referenced in the provided context is Azathioprine.","According to the context, the potential withdrawal symptoms associated with benzodiazepines include:\\n\\n* abnormal involuntary movements\\n* anxiety\\n* blurred vision\\n* depersonalization\\n* depression\\n* derealization\\n* dizziness\\n* fatigue\\n* gastrointestinal adverse reactions (e.g., nausea, vomiting, diarrhea, weight loss, decreased appetite)\\n* headache\\n* hyperacusis\\n* hypertension\\n* irritability\\n* insomnia\\n* memory impairment\\n* muscle pain and stiffness\\n* panic attacks\\n* photophobia\\n* restlessness\\n* tachycardia\\n* tremor\\n\\nAs for how long these withdrawal symptoms can persist in some cases, the context does not provide a specific answer. It only lists the potential withdrawal symptoms without specifying their duration.","I don&#x27;t know. The question does not provide any information about a specific document labeled as \\"document 23\\". The provided documents are labeled as \\"doc_9.pdf\\" and \\"doc_6.pdf\\", but there is no document 23 mentioned.","According to the context, Neonates born to mothers using benzodiazepines during the later stages of pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal.","According to the context, the severe consequences that may arise from the simultaneous use of benzodiazepines and opioids include:\\n\\n* Profound sedation\\n* Respiratory depression\\n* Coma\\n* Death\\n\\nTo mitigate these risks, it is recommended to:\\n\\n* Reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate\\n* Prescribe the lowest effective dosages and minimum durations of concomitant use\\n* Follow patients closely for signs and symptoms of respiratory depression and sedation\\n* Advise both patients and caregivers about the risks of respiratory depression and sedation when chlordiazepoxide hydrochloride and clidinium bromide is used with opioids.","According to the provided document, the active ingredients present in chlordiazepoxide hydrochloride and clidinium bromide capsules are:\\n\\n* Chlordiazepoxide hydrochloride\\n* Clidinium bromide","Based on the provided context, I do not have enough information to answer this question. The provided documents do not mention the item code \\"NDC:73097-009\\". Therefore, I do not know the names and strengths of the active ingredients found in the tablet identified by that item code.","According to the context, the potential dangers associated with the consumption of chlordiazepoxide hydrochloride and clidinium bromide capsules when combined with opioid medications, alcohol, or other central nervous system depressants include:\\n\\n* Severe drowsiness\\n* Breathing problems (respiratory depression)\\n* Coma\\n* Death\\n\\nAdditionally, if any of these symptoms occur, it is advised to seek emergency help immediately.","According to the provided context, the factors that should be considered when determining the maintenance dose for chlordiazepoxide hydrochloride and clidinium bromide capsules are:\\n\\n* Diagnosis\\n* Response of the individual patient\\n\\nThe usual recommended maintenance dose regimen is 1 or 2 capsules, taken 3 or 4 times a day, administered before meals and at bedtime.","Based on the provided context, Ivermectin lotion is primarily used to treat head lice. According to the document, it \\"treats head lice\\" and has warnings for external use only, not to be used on children under 6 months of age, near the eyes, inside the nose, ear, mouth, or vagina, or on lice in eyebrows or eyelashes.","Based on the provided context, the answer is:\\n\\nThe active ingredients present in each chlordiazepoxide hydrochloride and clidinium bromide capsule, USP are:\\n\\n1. Chlordiazepoxide hydrochloride, USP: 5 mg\\n2. Clidinium bromide, USP: 2.5 mg","Based on the provided context, it can be answered as follows:\\n\\nAccording to the document, chlordiazepoxide hydrochloride and clidinium bromide capsules are used in the treatment of anxiety states where there is any evidence of impending depression. It should be borne in mind that suicidal tendencies may be present and protective measures may be necessary.\\n\\nAs for the precautions to prevent misuse and abuse of this medication:\\n\\nThe document mentions that patients should be informed about the signs and symptoms of benzodiazepine abuse, misuse, and addiction; and on the proper disposal of unused drug.","According to the provided context, some of the severe adverse reactions that have been reported specifically with benzodiazepine abuse and/or misuse include:\\n\\n* Delirium\\n* Paranoia\\n* Suicidal ideation and behavior\\n* Seizures\\n* Coma\\n* Breathing difficulty\\n* Death\\n\\nThese reactions are often associated with an increased risk of polysubstance use, especially when benzodiazepines are used with other CNS depressants such as opioids and alcohol.","Based on the context, the specific active ingredients present in NyQuil Severe Cold &amp; Flu caplets are:\\n\\n1. Acetaminophen (325 mg) - Pain reliever/fever reducer\\n2. Dextromethorphan HBr (10 mg) - Cough suppressant\\n3. Doxylamine succinate (6.25 mg) - Antihistamine and Nasal decongestant\\n4. Phenylephrine HCL (5 mg) - Nasal decongestant\\n\\nThese purposes are stated in the \\"Drug Facts\\" section of the document.","According to the provided document, Walgreen Company&#x27;s marketing activities started on 05/06/2020.","Based on the context, the specific medical conditions and circumstances that would prevent someone from taking chlordiazepoxide hydrochloride and clidinium bromide capsules are:\\n\\n1. Have glaucoma\\n2. Have an enlarged prostate\\n3. Have a blockage of your bladder that causes problems with urination\\n4. Be allergic to chlordiazepoxide hydrochloride or clidinium bromide\\n\\nThese conditions are explicitly mentioned in the text as reasons why someone should not take the capsules.","According to the provided context, the potential signs and symptoms associated with an anticholinergic overdosage are:\\n\\nPeripheral signs and symptoms: dry mucous membranes and skin, flushing, tachycardia, hypertension, ileus, urinary retention, and mydriasis.\\n\\nCentral signs and symptoms: agitation and delirium, seizures, and hyperthermia.\\n\\nBenzodiazepines are considered a first-line treatment for anticholinergic toxicity, acting to treat mild to moderate agitation and prevent seizures. However, overdosage of benzodiazepines in combination with other CNS depressants (including alcohol and opioids) may be fatal.","According to the provided context, patients should be informed about the following important considerations:\\n\\n1. The risk of abuse, misuse, and addiction, which can lead to overdose and death, especially when used in combination with other medications (e.g., opioid analgesics), alcohol, and/or illicit substances.\\n2. The signs and symptoms of benzodiazepine abuse, misuse, and addiction.\\n3. The need to seek medical help if they develop these signs and/or symptoms.\\n4. Proper disposal of unused drug.","I don&#x27;t know. The provided context only mentions that \\"no side effects or manifestations not seen with either compound alone have been reported\\" and notes that the possibility of untoward effects cannot be excluded. It does not specify any potential side effects beyond those already listed (drowsiness, ataxia, and confusion).","According to the context, some of the adverse reactions reported during therapy with chlordiazepoxide hydrochloride include:\\n\\n* Isolated instances of skin eruptions\\n* Edema\\n* Minor menstrual irregularities\\n* Nausea and constipation\\n* Extrapyramidal symptoms\\n* Increased and decreased libido\\n\\nAnd some of the specific symptoms that have been reported are:\\n\\n* Dryness of the mouth\\n* Blurring of vision\\n* Urinary hesitancy\\n* Constipation","According to the provided context, patients who are:\\n\\n* Pregnant or plan to become pregnant: They should tell their healthcare provider right away if they become pregnant or think they are pregnant during treatment with chlordiazepoxide hydrochloride and clidinium bromide capsules. Taking these capsules late in pregnancy may cause symptoms of sedation and/or withdrawal symptoms in the baby.\\n\\n* Breastfeeding or plan to breastfeed: They should talk to their healthcare provider about the best way to feed their baby if they take chlordiazepoxide hydrochloride and clidinium bromide capsules. These capsules may pass through breast milk and cause sedation, poor feeding, or poor weight gain in the baby. Chlordiazepoxide hydrochloride and clidinium bromide capsules may also decrease the amount of breast milk their body makes.","According to the document, the marketing of the product from Savings Distributors LLC began on July 8, 2019. This is stated in the line \\"Marketing Start Date\\\\n07/08/2019\\" on page 4 of the document.","According to the context, the answer is:\\n\\nThe active ingredients present in the chlordiazepoxide hydrochloride and clidinium bromide capsule are:\\n\\n* Chlordiazepoxide hydrochloride, USP: 5 mg\\n* Clidinium bromide, USP: 2.5 mg"]],["reference_answer",["Chlordiazepoxide hydrochloride and clidinium bromide capsules are contraindicated in the presence of glaucoma, in patients with prostatic hypertrophy and benign bladder neck obstruction, and in patients with known hypersensitivity to chlordiazepoxide hydrochloride and/or clidinium bromide.","The color of the capsule for the product with NDC code 62332-744-31 is light green, with a light green opaque cap and body.","Ivermectin","Withdrawal symptoms of benzodiazepine use can include acute withdrawal reactions such as seizures, protracted withdrawal syndrome lasting weeks to over 12 months, and neonatal sedation and withdrawal syndrome in babies born to mothers who used benzodiazepines late in pregnancy.","The net weight of the tube is 4 ounces (117 grams).","Benzodiazepines crossing the placenta may produce respiratory depression, hypotonia, and sedation in neonates. Neonates exposed to chlordiazepoxide hydrochloride and clidinium bromide capsules during pregnancy or labor should be monitored for signs of sedation, respiratory depression, hypotonia, and feeding problems.","The risks associated with the concomitant use of benzodiazepines and opioids include profound sedation, respiratory depression, coma, and death. It is advised to reserve concomitant prescribing of these drugs for patients when alternative treatment options are inadequate, limit dosages and durations to the minimum required, and closely monitor patients for signs of respiratory depression and sedation.","The active ingredients in chlordiazepoxide hydrochloride and clidinium bromide capsules are chlordiazepoxide hydrochloride and clidinium bromide.","The active ingredients in the tablet with item code NDC:73097-009 are Acetaminophen (325 mg), Dextromethorphan Hydrobromide (10 mg), Doxylamine Succinate (6.25 mg), and Phenylephrine Hydrochloride (5 mg).","Taking chlordiazepoxide hydrochloride and clidinium bromide capsules with opioid medicines, alcohol, or other central nervous system depressants can cause severe drowsiness, breathing problems, coma, and death. There is also a risk of abuse, misuse, and addiction with benzodiazepines, including this medication.","The usual maintenance dose is 1 or 2 capsules, 3 or 4 times a day administered before meals and at bedtime.","The purpose of Ivermectin lotion is to treat head lice.","Each capsule contains 5 mg of chlordiazepoxide hydrochloride, USP and 2.5 mg of clidinium bromide, USP.","Chlordiazepoxide hydrochloride and clidinium bromide capsule is a prescription medicine used in conjunction with other therapies for the treatment of stomach (peptic) ulcers, irritable bowel syndrome (IBS), and inflammation of the colon known as acute enterocolitis.","Some severe adverse reactions that have occurred with benzodiazepine abuse and/or misuse include delirium, paranoia, suicidal ideation and behavior, seizures, coma, breathing difficulty, and death. Death is more often associated with polysubstance use, especially combining benzodiazepines with other CNS depressants such as opioids and alcohol.","The active ingredients in each NyQuil Severe Cold &amp; Flu caplet are Acetaminophen (325 mg), Dextromethorphan HBr (10 mg), Doxylamine succinate (6.25 mg), and Phenylephrine HCL (5 mg).","The marketing start date for Walgreen Company was 05/06/2020.","You should not take chlordiazepoxide hydrochloride and clidinium bromide capsules if you have glaucoma, an enlarged prostate, a bladder blockage causing urination problems, or if you are allergic to chlordiazepoxide or clidinium bromide.","Signs and symptoms of anticholinergic overdosage may include dry mucous membranes and skin, flushing, tachycardia, hypertension, ileus, urinary retention, mydriasis, garbled speech, agitation, delirium, seizures, and hyperthermia.","Patients should be informed about the risks of abuse, misuse, and addiction associated with the use of chlordiazepoxide hydrochloride and clidinium bromide capsules. They should also be aware of the signs and symptoms of benzodiazepine abuse, misuse, and addiction, and be advised to seek medical help if they experience these. Additionally, patients should be informed about the potential withdrawal reactions that may occur upon discontinuation or rapid dosage reduction of the capsules.","The most common side effects of chlordiazepoxide hydrochloride and clidinium bromide capsules include dry mouth, nausea, skin problems, blurred vision, constipation, swelling, irregular menstrual cycles, changes in libido, problems with urination, drowsiness, coordination problems, and confusion, especially in elderly or weak individuals.","Some adverse reactions reported during therapy with chlordiazepoxide hydrochloride and clidinium bromide capsules include skin eruptions, edema, minor menstrual irregularities, nausea, constipation, extrapyramidal symptoms, changes in EEG patterns, blood dyscrasias such as agranulocytosis, jaundice, hepatic dysfunction, dryness of the mouth, blurring of vision, urinary hesitancy, and constipation.","Patients should inform their healthcare provider if they are pregnant or breastfeeding while taking chlordiazepoxide hydrochloride and clidinium bromide capsules.","The marketing start date for the product from Savings Distributors LLC is 07/08/2019.","The active ingredients in the chlordiazepoxide hydrochloride and clidinium bromide capsule are Chlordiazepoxide Hydrochloride with a strength of 5 mg and Clidinium Bromide with a strength of 2.5 mg."]],["id",[2,19,26,4,23,7,0,17,32,13,12,20,1,14,10,29,28,15,11,5,16,9,6,33,18]],["content",["the maximum recommended human dose of 40 mg/day, based on body surface area)\\nexhibited major skeletal defects.\\nTwo series of reproduction experiments with clidinium bromide were carried out in rats,\\nemploying dosages of 2.5 and 10 mg/kg daily (1.2 and 4.9 times, respectively, the\\nmaximum recommended clinical dose of 20 mg/day, based on body surface area) in\\neach experiment. In the first experiment, clidinium bromide was administered for a 9-\\nweek interval prior to mating; no untoward effect on f...","Alembic Pharmaceuticals Inc.\\nPOTASSIUM HYDROXIDE\\n (UNII: WZH3C48M4T)\\n \\nPROPYLENE GLYCOL\\n (UNII: 6DC9Q167V3)\\n \\nProduct Characteristics\\nColor\\nGREEN (Light green opaque cap) , GREEN (Light green opaque body)\\nScore\\nno score\\nShape\\nCAPSULE\\nSize\\n16mm\\nFlavor\\nImprint Code\\nA;333\\nContains\\n    \\nPackaging\\n#\\nItem Code\\nPackage Description\\nMarketing Start\\nDate\\nMarketing End\\nDate\\n1\\nNDC:62332-744-\\n31\\n100 \\nin 1 BOTTLE; Type 0: Not a Combination\\nProduct\\n10/04/2023\\n2\\nNDC:62332-744-\\n91\\n1000 \\nin 1 BOTTLE; Type 0: Not ...","IVERMECTIN","those who have had longer durations of use.\\nAcute Withdrawal Reactions\\nThe continued use of benzodiazepines, including chlordiazepoxide hydrochloride and\\nclidinium bromide capsules, may lead to clinically significant physical dependence. Abrupt\\ndiscontinuation or rapid dosage reduction of chlordiazepoxide hydrochloride and\\nclidinium bromide capsules after continued use, or administration of flumazenil (a\\nbenzodiazepine antagonist) may precipitate acute withdrawal reactions, which can be\\nlife-thr...","1\\nTUBE\\nNET WT 4 OZ (117 g)","defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to\\n20%, respectively.\\nClinical Considerations\\nFetal/Neonatal Adverse Reactions\\nBenzodiazepines cross the placenta and may produce respiratory depression, hypotonia\\nand sedation in neonates. Monitor neonates exposed to chlordiazepoxide hydrochloride\\nand clidinium bromide capsules, which contains a benzodiazepine (chlordiazepoxide\\nhydrochloride), during pregnancy or labor for signs of sedation, respiratory depression,...","CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE -\\nchlordiazepoxide hydrochloride and clidinium bromide capsule \\n \\nAlembic Pharmaceuticals Inc.\\n----------\\nChlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP\\nfor oral use\\nWARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE,\\nMISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL\\nREACTIONS\\n \\nConcomitant use of benzodiazepines and opioids may result in\\nprofound sedation, respiratory depression, coma, and death. Reserve\\nconcomitan...","that is written for health professionals.\\nWhat are the ingredients in chlordiazepoxide hydrochloride and clidinium\\nbromide capsules? \\nActive ingredients:\\n chlordiazepoxide hydrochloride and clidinium bromide \\nInactive ingredients: \\nlactose monohydrate, corn starch, talc, titanium dioxide, FD&amp;C\\nGreen 3, D&amp;C Yellow 10 and gelatin. The empty hard gelatin capsule shells are printed\\nwith edible black ink containing shellac, propylene glycol,  iron oxide and black iron oxide\\nand potassium hydroxide. \\n...","acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride tablet, coated\\nProduct Information\\nProduct Type\\nHUMAN OTC DRUG\\nItem Code (Source)\\nNDC:73097-009(NDC:37000-813)\\nRoute of Administration\\nORAL\\nActive Ingredient/Active Moiety\\nIngredient Name\\nBasis of Strength\\nStrength\\nACETAMINOPHEN\\n (UNII: 362O9ITL9D) \\n(ACETAMINOPHEN - UNII:362O9ITL9D)\\nACETAMINOPHEN\\n325 mg\\nDEXTROMETHORPHAN HYDROBROMIDE\\n (UNII: 9D2RTI9KYH)\\n(DEXTROMETHORPHAN - UNII:7355X3ROTS)\\nDEXTROMETHOR...","on cap and \\u201c333\\u201d on body with black ink, filled with white to off white powder.\\nBottle of 100 capsules with child resistant closure, NDC 62332-744-31\\nBottle of 1000 capsules, NDC 62332-744-91\\nStore at 25\\u00b0C (77\\u00b0F); excursions permitted to 15\\u00b0 to 30\\u00b0C (59\\u00b0 to 86\\u00b0F) [see USP\\nControlled Room Temperature]. Protect from light.\\nKeep out of reach of children.\\nDispense in tight, light-resistant container as defined in USP/NF.\\nMedication Guide available at \\nhttps://www.alembicusa.com/medicationguide.aspx ...","overdosage. Anticholinergic drugs usually increase heart rate and blood pressure. In\\nmanaging benzodiazepine overdosage, employ general supportive measures, including\\nintravenous fluids, and airway management.\\nFlumazenil, a specific benzodiazepine receptor antagonist is indicated for the complete\\nor partial reversal of the sedative effects of benzodiazepines in the management of\\nbenzodiazepine overdosage. Use of flumazenil may increase the risk of seizures in\\nmixed overdosage with drugs that may...","IVERMECTIN- ivermectin lotion \\n \\nWalgreen Company\\n----------\\nIvermectin\\nDrug Facts\\nActive ingredient\\nIvermectin 0.5%\\nPurpose\\nLice treatment\\nUse\\ntreats head lice\\nWarnings\\nFor external use only. Use only on the scalp.\\nDo not use\\non children under 6 months of age\\nnear the eyes\\ninside the nose, ear, mouth, or vagina\\non lice in eyebrows or eyelashes. See a doctor if lice are present in these areas.\\nAsk a doctor before use if you\\nhave any skin conditions or sensitivities\\nare pregnant or plan to become...","Each chlordiazepoxide hydrochloride and clidinium bromide capsule, USP contains the\\nactive ingredients 5 mg chlordiazepoxide hydrochloride, USP and 2.5 mg clidinium\\nbromide, USP. Each capsule also contains the inactive ingredients lactose monohydrate,\\ncorn starch, talc, titanium dioxide, FD&amp;C Green 3, D&amp;C Yellow 10 and gelatin. The empty\\nhard gelatin capsule shells are printed with edible black ink containing shellac, propylene\\nglycol,  black iron oxide and potassium hydroxide.\\nChlordiazepoxide ...","bromide capsules, which can lead to overdose or death. \\n        o \\nSerious side effects including coma and death have happened in people\\nwho have abused or misused benzodiazepines, including chlordiazepoxide\\nhydrochloride and clidinium bromide capsules. \\nThese serious side effects may also\\ninclude delirium, paranoia, suicidal thoughts or actions, seizures, and difficulty breathing.\\nCall your healthcare provider or go to the nearest hospital emergency room\\nright away if you get any of these serio...","Abuse and misuse of benzodiazepines often (but not always) involve the use of doses\\ngreater than the maximum recommended dosage and commonly involve concomitant\\nuse of other medications, alcohol, and/or illicit substances, which is associated with an\\nincreased frequency of serious adverse outcomes, including respiratory depression,\\noverdose, or death. Benzodiazepines are often sought by individuals who abuse drugs\\nand other substances, and by individuals with addictive disorders (see \\nWARNINGS\\n)...","NYQUIL SEVERE COLD AND FLU- acetaminophen, dextromethorphan hydrobromide,\\ndoxylamine succinate, phenylephrine hydrochloride tablet, coated \\n \\nSavings Distributors LLC\\nDisclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they\\ncomply with applicable regulations and policies. FDA has not evaluated whether this product complies.\\n----------\\nNyQuil Severe Cold &amp; Flu\\nDrug Facts\\nActive ingredients (in each caplet)\\nAcetaminophen 325 mg\\nDextromethorphan HBr 10 m...","Walgreen Company\\nMarketing Information\\nMarketing\\nCategory\\nApplication Number or Monograph\\nCitation\\nMarketing Start\\nDate\\nMarketing End\\nDate\\nANDA\\nANDA210720\\n05/06/2020\\nLabeler - \\nWalgreen Company \\n(008965063)\\n \\nRevised: 1/2022","clidinium bromide capsules may harm others. Tell your healthcare provider if you have\\nabused or been dependent on alcohol, prescription medicines or street drugs. \\n\\u2022 It is not known if chlordiazepoxide hydrochloride and clidinium bromide capsule is safe\\nand effective in children. \\n \\nDo not take chlordiazepoxide hydrochloride and clidinium bromide capsules if\\nyou: \\n\\u2022 have glaucoma \\n\\u2022 have an enlarged prostate \\n\\u2022 have a blockage of your bladder that causes problems with urination \\n\\u2022 are allergic t...","seizures and suicidality.\\nProtracted Withdrawal Syndrome\\nProtracted withdrawal syndrome associated with benzodiazepines is characterized by\\nanxiety, cognitive impairment, depression, insomnia, formication, motor symptoms (e.g.,\\nweakness, tremor, muscle twitches), paresthesia, and tinnitus that persists beyond 4 to\\n6 weeks after initial benzodiazepine withdrawal. Protracted withdrawal symptoms may\\nlast weeks to more than 12 months. As a result, there may be difficulty in differentiating\\nwithdrawa...","as the MAO inhibitors and phenothiazines are to be used. The usual precautions in\\ntreating patients with impaired renal or hepatic function should be observed.\\nParadoxical reactions to chlordiazepoxide hydrochloride, e.g., excitement, stimulation\\nand acute rage, have been reported in psychiatric patients and should be watched for\\nduring chlordiazepoxide hydrochloride and clidinium bromide capsules therapy. The\\nusual precautions are indicated when chlordiazepoxide hydrochloride is used in the\\ntre...","hydrochloride and clidinium bromide capsules or suddenly stop taking chlordiazepoxide\\nhydrochloride and clidinium bromide capsules without talking with your healthcare\\nprovider. \\n\\u2022 If you take too much chlordiazepoxide hydrochloride and clidinium bromide capsules,\\ncall your healthcare provider or go to the nearest hospital emergency room right away. \\nWhat are the possible side effects of chlordiazepoxide hydrochloride and\\nclidinium bromide capsules? \\nChlordiazepoxide hydrochloride and clidinium ...","instances syncope has been reported.\\nOther adverse reactions reported during therapy with chlordiazepoxide hydrochloride\\ninclude isolated instances of skin eruptions, edema, minor menstrual irregularities,\\nnausea and constipation, extrapyramidal symptoms, as well as increased and decreased\\nlibido. Such side effects have been infrequent and are generally controlled with reduction\\nof dosage. Changes in EEG patterns (low-voltage fast activity) have been observed in\\npatients during and after chlordi...","Pregnancy\\n). Instruct patients to inform their healthcare provider if they are pregnant.\\nNursing\\nInstruct patients to notify their healthcare provider if they are breastfeeding or intend to\\nbreastfeed (see \\nPRECAUTIONS, Nursing Mothers\\n).\\nDrug Interactions\\nOpioids\\n \\nThe concomitant use of benzodiazepines, including chlordiazepoxide hydrochloride, a\\ncomponent of chlordiazepoxide hydrochloride and clidinium bromide capsules and\\nopioids increases the risk of respiratory depression because of action...","Savings Distributors LLC\\n3\\nNDC:73097-009-20\\n40 \\nin 1 CARTON\\n07/08/2019\\n3\\n2 \\nin 1 POUCH; Type 0: Not a Combination Product\\nMarketing Information\\nMarketing Category\\nApplication Number or Monograph Citation\\nMarketing Start Date\\nMarketing End Date\\nOTC monograph final\\npart341\\n07/08/2019\\nLabeler - \\nSavings Distributors LLC \\n(010527359)\\n \\nRevised: 7/2019","CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE  \\nchlordiazepoxide hydrochloride and clidinium bromide capsule\\nProduct Information\\nProduct Type\\nHUMAN PRESCRIPTION DRUG\\nItem Code (Source)\\nNDC:62332-744\\nRoute of Administration\\nORAL\\nDEA Schedule\\nCIV    \\nActive Ingredient/Active Moiety\\nIngredient Name\\nBasis of Strength\\nStrength\\nCHLORDIAZEPOXIDE HYDROCHLORIDE\\n (UNII: MFM6K1XWDK)\\n(CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR)\\nCHLORDIAZEPOXIDE\\nHYDROCHLORIDE\\n5 mg\\nCLIDINIUM BROMIDE\\n (UNII: 91ZQW5JF1Z) \\n(CLIDI..."]],["color",["#ba0e0e","#ba0e0e","#ba0e0e","#ba0e0e","#ba0e0e","#ba0e0e","#0a980a","#0a980a","#0a980a","#ba0e0e","#0a980a","#0a980a","#0a980a","#ba0e0e","#0a980a","#0a980a","#0a980a","#0a980a","#ba0e0e","#ba0e0e","#ba0e0e","#ba0e0e","#0a980a","#0a980a","#0a980a"]]]}}},"view":{"type":"object","name":"CDSView","id":"p2486","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p2487"}}},"glyph":{"type":"object","name":"Scatter","id":"p2482","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.7},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.7}}},"nonselection_glyph":{"type":"object","name":"Scatter","id":"p2483","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.1},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.1},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"Scatter","id":"p2484","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.2},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.2}}}}},{"type":"object","name":"GlyphRenderer","id":"p2500","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p2491","attributes":{"selected":{"type":"object","name":"Selection","id":"p2492","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p2493"},"data":{"type":"map","entries":[["x",{"type":"ndarray","array":{"type":"bytes","data":"QDUKQcDUDUF1RQFBgF4AQd9P9ECEsfFAHvEKQTdzEkE3BRFBDNraQLhC10AuV+pAV74EQWQEFkHehOlAW38HQUav/0AZuBhBb/wgQZb0LUGYrytBrJ8iQe19NUHPt0JB4WYqQVyoN0FxljpBTegzQUSvJ0G1oStBsd47QQCfRkE="},"shape":[32],"dtype":"float32","order":"little"}],["y",{"type":"ndarray","array":{"type":"bytes","data":"9PKZwBIxscDbIrvAmYlcwK9wfsBy5pPAX8ZAwHf8ZMANVozA7OiawFuGdcB6+lTAhmaEwAuUoMCCyrfALfrKwFKmo8BvPLvA2TChwD7jocAittzA6nPUwKcg1MBYKsDAgi6+wNuDw8Dk8KnA1VJewAFAacCP9YjAO0KPwD3PpMA="},"shape":[32],"dtype":"float32","order":"little"}]]}}},"view":{"type":"object","name":"CDSView","id":"p2501","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p2502"}}},"glyph":{"type":"object","name":"Scatter","id":"p2497","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"value","value":"grey"},"line_alpha":{"type":"value","value":0.2},"fill_color":{"type":"value","value":"grey"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"value","value":"grey"},"hatch_alpha":{"type":"value","value":0.2}}},"nonselection_glyph":{"type":"object","name":"Scatter","id":"p2498","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"value","value":"grey"},"line_alpha":{"type":"value","value":0.1},"fill_color":{"type":"value","value":"grey"},"fill_alpha":{"type":"value","value":0.1},"hatch_color":{"type":"value","value":"grey"},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"Scatter","id":"p2499","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"value","value":"grey"},"line_alpha":{"type":"value","value":0.2},"fill_color":{"type":"value","value":"grey"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"value","value":"grey"},"hatch_alpha":{"type":"value","value":0.2}}}}}],"toolbar":{"type":"object","name":"Toolbar","id":"p2454","attributes":{"logo":"grey","tools":[{"type":"object","name":"PanTool","id":"p2469"},{"type":"object","name":"WheelZoomTool","id":"p2470","attributes":{"renderers":"auto"}},{"type":"object","name":"BoxZoomTool","id":"p2471","attributes":{"overlay":{"type":"object","name":"BoxAnnotation","id":"p2472","attributes":{"syncable":false,"level":"overlay","visible":false,"left":{"type":"number","value":"nan"},"right":{"type":"number","value":"nan"},"top":{"type":"number","value":"nan"},"bottom":{"type":"number","value":"nan"},"left_units":"canvas","right_units":"canvas","top_units":"canvas","bottom_units":"canvas","line_color":"black","line_alpha":1.0,"line_width":2,"line_dash":[4,4],"fill_color":"lightgrey","fill_alpha":0.5}}}},{"type":"object","name":"ResetTool","id":"p2477"},{"type":"object","name":"SaveTool","id":"p2478"},{"type":"object","name":"HoverTool","id":"p2445","attributes":{"renderers":[{"id":"p2485"}],"tooltips":"\\n    &lt;div style=\\"width:400px;\\"&gt;\\n    &lt;b&gt;Document id:&lt;/b&gt; @id &lt;br&gt;\\n    &lt;b&gt;Topic:&lt;/b&gt; @topic &lt;br&gt;\\n    &lt;b&gt;Question:&lt;/b&gt; @questions &lt;br&gt;\\n    &lt;b&gt;agent Answer:&lt;/b&gt; @agent_answer &lt;br&gt;\\n    &lt;b&gt;Reference Answer:&lt;/b&gt; @reference_answer &lt;br&gt;\\n    &lt;b&gt;Correctness:&lt;/b&gt; @correctness &lt;br&gt;\\n    &lt;b&gt;Content:&lt;/b&gt; @content\\n    &lt;/div&gt;\\n    "}}]}},"left":[{"type":"object","name":"LinearAxis","id":"p2464","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p2465","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p2466"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p2467"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"below":[{"type":"object","name":"LinearAxis","id":"p2459","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p2460","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p2461"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p2462"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"center":[{"type":"object","name":"Grid","id":"p2463","attributes":{"axis":{"id":"p2459"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Grid","id":"p2468","attributes":{"dimension":1,"axis":{"id":"p2464"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Legend","id":"p2488","attributes":{"title":"Question Correctness","title_text_color":"#B1B1B1","title_text_font_style":"bold","border_line_alpha":0,"background_fill_color":"#111516","background_fill_alpha":0.5,"label_text_color":"#E0E0E0","label_text_font":"Helvetica","label_text_font_size":"1.025em","label_standoff":8,"glyph_width":15,"spacing":8,"items":[{"type":"object","name":"LegendItem","id":"p2489","attributes":{"label":{"type":"value","value":"False"},"renderers":[{"id":"p2485"}],"index":0}},{"type":"object","name":"LegendItem","id":"p2490","attributes":{"label":{"type":"value","value":"True"},"renderers":[{"id":"p2485"}],"index":6}}]}}],"background_fill_color":"#14191B","border_fill_color":"#15191C"}}}}],"tabs_location":"below"}}]}}';
        const render_items = [{"docid":"f8910ba5-41ae-4b2a-8117-cddff78f25c8","roots":{"p2504":"c8f2f312-249e-40ab-8678-128ac1e28c61"},"root_ids":["p2504"]}];
        root.Bokeh.embed.embed_items(docs_json, render_items);
        }
        if (root.Bokeh !== undefined) {
          embed_document(root);
        } else {
          let attempts = 0;
          const timer = setInterval(function(root) {
            if (root.Bokeh !== undefined) {
              clearInterval(timer);
              embed_document(root);
            } else {
              attempts++;
              if (attempts > 100) {
                clearInterval(timer);
                console.log("Bokeh: ERROR: Unable to run BokehJS code because BokehJS library is missing");
              }
            }
          }, 10, root)
        }
      })(window);
    });
  };
  if (document.readyState != "loading") fn();
  else document.addEventListener("DOMContentLoaded", fn);
})();
    </script>

                <div id="c8f2f312-249e-40ab-8678-128ac1e28c61" data-root-id="p2504" style="display: contents;"></div>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">

                <div class="section-title">SELECTED METRICS</div>

                

            </div>
        </div>

        
    </div>
</div>



<script type="text/javascript">
    function opentab(evt, name) {
    // Declare all variables
    let i, tabcontent, tablinks;

    // Get all elements with class="tabcontent" and hide them
    tabcontent = document.getElementsByClassName("tabcontent");
    for (i = 0; i < tabcontent.length; i++) {
        tabcontent[i].style.display = "none";
    }

    // Get all elements with class="tablinks" and remove the class "active"
    tablinks = document.getElementsByClassName("tablinks");
    for (i = 0; i < tablinks.length; i++) {
        tablinks[i].className = tablinks[i].className.replace(" active", "");
    }

    // Show the current tab, and add an "active" class to the button that opened the tab
    document.getElementById(name).style.display = "block";
    evt.currentTarget.className += " active";
}
</script>
